(Q39538849)

12 September 2017

title

The effectiveness of nalbuphine and hydroxyzine for the emergency treatment of severe headache (English)

1 reference

12 September 2017

1 reference

Tek D

1

1 reference

12 September 2017

Mellon M

series ordinal

2

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 March 1987

1 reference

Annals of Emergency Medicine

12 September 2017

published in

1 reference

12 September 2017

volume

16

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

308-313

1 reference

Non-traumatic headache in the emergency department

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Classification of migraine and tension headache from a survey of 10,000 headache diaries

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Migraine: definition and classification

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Endorphins, Opiate Receptors and Migraine Headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Endorphin levels in headache syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Endogenous Opioids in Cerebrospinal Fluid and Blood in Idiopathic Headache Sufferers

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Primary Headaches: Reduced Circulating β-Lipotropin and β-Endorphin Levels with Impaired Reactivity to Acupuncture

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Hypothesis: migraine, a central biochemical dysnociception

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Naloxone Effectiveness on Spontaneous and Induced Perceptive Disorders in Migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Impaired 5-Hydroxytryptamine Tachyphylaxis in Migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Pharmacokinetics and Mechanisms of Action of Analgesics in Clinical Pain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Migraine. Current concepts of pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Migraine, Headache, and Related Conditions--Panel 7

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Current concepts. Headache

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Use of Ergot Preparations in Acute Migraine Attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Pharmacology of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Parenteral chlorpromazine treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Nalbuphine versus meperidine for postoperative analgesia: A double-blind comparison using the patient controlled analgesic technique

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Comparison of the Analgesic Effects of Intravenous Nalbuphine and Pentazocine in Patients with Postoperative Pain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Analgesic effects of oral nalbuphine and codeine in patients with postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Evaluation of nalbuphine for abuse potential.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Nalbuphine A Preliminary Review of its Pharmacological Properties and Therapeutic Efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Substitution and primary dependence studies in animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Analgesic effectiveness of the narcotic agonist-antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Human pharmacology of narcotic antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Ceiling effect for respiratory depression by nalbuphine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Analgesic and respiratory depressant activity of nalbuphine: a comparison with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Butorphanol and nalbuphine: a pharmacologic comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Cardiorespiratory effects of nalbuphine and morphine premedication in adult cardiac surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

Hemodynamic effects of morphine and nalbuphine in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980177-4

7 January 2021

10.1016/S0196-0644(87)80177-4

Identifiers

DOI

1 reference

release_pv5t2pmzsjfavjdueswyk5c76q

12 September 2017

Fatcat ID

0 references

1 reference